NEXGEL And Innovative Optics US Initiate IRB Study In Accordance With FDA Of Hydrogel Application During Laser Hair Removal
Portfolio Pulse from Benzinga Newsdesk
NEXGEL, Inc. (NASDAQ:NXGL) and Innovative Optics US have initiated an IRB study to measure the efficacy of NEXGEL's hydrogel in eliminating harmful particles during laser hair removal. The study is funded by Innovative Optics US and aligns with FDA guidelines. Several states are considering mandates for surgical plume protection.
July 18, 2024 | 1:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
NEXGEL, Inc. has initiated an IRB study with Innovative Optics US to evaluate the benefits of its hydrogel in laser hair removal, potentially leading to new regulatory mandates.
The initiation of the IRB study aligns with FDA guidelines and could lead to new regulatory mandates for surgical plume protection, potentially increasing demand for NEXGEL's hydrogel products.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100